These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 3418286)

  • 21. THE PREVENTION OF CERVICAL CANCER. WHO TAKES THE SMEARS?
    WOLFENDALE M; HANDFIELD-JONES RP
    Lancet; 1964 Oct; 2(7365):901-2. PubMed ID: 14197196
    [No Abstract]   [Full Text] [Related]  

  • 22. Hysterectomy prevalence and adjusted cervical and uterine cancer rates in England and Wales.
    Redburn JC; Murphy MF
    BJOG; 2001 Apr; 108(4):388-95. PubMed ID: 11305546
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mass population screening for cervix cancer.
    Christopherson WM
    Tumori; 1976; 62(3):297-301. PubMed ID: 1014125
    [No Abstract]   [Full Text] [Related]  

  • 24. [A retrospective study of carcinoma of the uterine cervix and the value of cytological cervix studies in healthy women].
    Barentsz JO; Muizebelt F; van der Schee AC; Toonen-van Beek AA
    Ned Tijdschr Geneeskd; 1979 Nov; 123(45):1932-6. PubMed ID: 514382
    [No Abstract]   [Full Text] [Related]  

  • 25. Recent trends in cervical cancer mortality in Britain and Ireland: the case for population-based cervical cancer screening.
    Comber H; Gavin A
    Br J Cancer; 2004 Nov; 91(11):1902-4. PubMed ID: 15545969
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapid onset cancer of the cervix.
    Macgregor JE
    Br Med J (Clin Res Ed); 1982 Feb; 284(6314):441-2. PubMed ID: 6800489
    [No Abstract]   [Full Text] [Related]  

  • 27. Decline in mortality from carcinoma of the cervix in Beverly, Mass.
    Lipworth L; Humphrey CB; Lloyd ED; Fienberg R
    Public Health Rep (1896); 1969 Sep; 84(9):826-30. PubMed ID: 4979884
    [No Abstract]   [Full Text] [Related]  

  • 28. "Pap" testing and hysterectomy prevalence: a survey of communities with high and low cervical cancer rates.
    Stern E; Misczynski M; Greenland S; Damus K; Coulson A
    Am J Epidemiol; 1977 Oct; 106(4):296-305. PubMed ID: 910797
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of cervical cytology in the declining morbidity and mortality of cervical cancer.
    Cramer DW
    Cancer; 1974 Dec; 34(6):2018-27. PubMed ID: 4434331
    [No Abstract]   [Full Text] [Related]  

  • 30. A cohort study of cervical cancer screening in British Columbia.
    Boyes DA; Morrison B; Knox EG; Draper GJ; Miller AB
    Clin Invest Med; 1982; 5(1):1-29. PubMed ID: 7116711
    [No Abstract]   [Full Text] [Related]  

  • 31. Cervical cancer in New Zealand: national and regional trends.
    Cox B; Borman B
    N Z Med J; 1994 Aug; 107(984):323-6. PubMed ID: 8072727
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytological mass screening of a defined population.
    Kolstad P
    Acta Obstet Gynecol Scand; 1969; 48(S3):50-7. PubMed ID: 5380825
    [No Abstract]   [Full Text] [Related]  

  • 33. Improved prognosis for cervical cancers due to comprehensive screening.
    Macgregor JE; Fraser ME; Mann EM
    Acta Cytol; 1972; 16(1):14-5. PubMed ID: 4501868
    [No Abstract]   [Full Text] [Related]  

  • 34. Letter: Screening for cervical cancer.
    Lancet; 1974 Jun; 1(7868):1221. PubMed ID: 4134347
    [No Abstract]   [Full Text] [Related]  

  • 35. Screening for cervical neoplasia. A survey of the assumptions from studies on the screening in Maribo Amt.
    Berget A
    Dan Med Bull; 1979 Nov; 26(7):313-32. PubMed ID: 118850
    [No Abstract]   [Full Text] [Related]  

  • 36. Report on a three-county cervical cancer screening project.
    Whitlock NH; Long SE; Kuemmerer JM
    J S C Med Assoc; 1972 Jun; 68(6):237-46. PubMed ID: 4504050
    [No Abstract]   [Full Text] [Related]  

  • 37. [Systematic screening for cancer of the uterine cervix (epidemiologic aspects)].
    Campion J; Flamant R
    Bull Inst Natl Sante Rech Med; 1966; 21(5):977-94. PubMed ID: 5976404
    [No Abstract]   [Full Text] [Related]  

  • 38. The cervical cancer screening programme in Norway, 1992-2000: changes in Pap smear coverage and incidence of cervical cancer.
    Nygård JF; Skare GB; Thoresen SØ
    J Med Screen; 2002; 9(2):86-91. PubMed ID: 12133929
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cervical cancer and cytology screening in New Zealand.
    Green GH
    Br J Obstet Gynaecol; 1978 Dec; 85(12):881-6. PubMed ID: 737153
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Experience of a continuing mass screening programme. Screening and re-screening for cervical carcinoma in Turku.
    Grönroos M; Tyrkkö J; Järvi O; Rauramo L
    Ann Chir Gynaecol Fenn; 1974; 63(6):470-8. PubMed ID: 4441027
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.